Annual Report

Overview

The report presents FY2018-19 consolidated revenue from operations of INR 131,656 million and highlights a research pipeline of six novel biologics and 21 biosimilars. It also reports CSR spending of INR 272.09 million on healthcare, education, water, and related initiatives.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2018-2019
Period: 1 April 2018 – 31 March 2019
Language: English
File size

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services